Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Kan. Senate votes for meth precursor e-tracking

This article was originally published in The Tan Sheet

Executive Summary

A statewide system for tracking purchases of nonprescription products containing ephedrine or pseudoephedrine is a step closer to reality after the Kansas Senate passes S.B. 248. Following its March 12 approval by 37-3 margin, the bill will next be considered in the state House. Other states have set up similar electronic logbooks to monitor purchases of methamphetamine precursors - including Tennessee, which says its statewide tracking system has been a success (1"The Tan Sheet" Feb. 2, 2009, p. 4). ... Mo. Senate votes down PSE Rx amendment: An attempt to amend a larger crime bill with a measure requiring a prescription for products containing methamphetamine precursors fails in the Missouri state Senate March 4. The amendment offered by state Sen. Jason Crowell, a Republican representing the Cape Girardeau area, "was soundly defeated" by voice vote, according to a legislature spokesman. Separately, Crowell has sponsored a bill, S.B. 160, to make cough/cold remedies containing ephedrine or pseudoephedrine available by prescription only, which remains viable (2"The Tan Sheet" Feb. 23, 2009, p. 3). A companion bill, H.B. 496, is under consideration in the House and has been passed out of committee

You may also be interested in...

Hurdles for PSE purchases in Louisiana bill

Buying ephedrine- or pseudoephedrine-containing products in the state becomes more difficult under legislation introduced April 3 by Rep. Fred Mills, a Democrat from the Parks, La., area. House Bill 177 would require pharmacists to ask for photo ID and record the purchase of any methamphetamine precursor for entry into the pharmacy's dispensing information system. Given the "devastating effect" of meth on people in Louisiana, the bill says a pharmacist is best qualified to weigh the benefits of dispensing a precursor product against the risk of illegal use. The Missouri Senate recently rejected a measure that would have made cough/cold products with ephedrine or PSE available by prescription only (1"The Tan Sheet" March 16, 2009, In Brief)

Iowa to track meth precursors

Gov. Chet Culver (D) signs a law establishing a real-time electronic repository to monitor sales of ephedrine- and pseudoephedrine-containing products in Iowa. Senate File 237, enacted March 25 and effective July 1, makes Iowa the seventh state to mandate electronic logbooks for purchases of nonprescription methamphetamine precursors, according to the National Association of Chain Drug Stores. Oklahoma, Arkansas, Kentucky and West Virginia actively track PSE sales. Hawaii and Missouri have approved but have yet to implement systems. The Kansas Senate has approved an electronic logbook bill (1"The Tan Sheet" March 16, 2009, In Brief)

Rite Aid Joins Fragmented Electronic Effort Against “Smurfing”

Some drugstore chains are tracking sales of methamphetamine precursors with their own electronic systems, but Sen. Chuck Grassley says a national approach may be needed to effectively prevent consumers from evading limits on retail purchases of the products

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts